176 related articles for article (PubMed ID: 18436959)
1. Conformational gating of dimannose binding to the antiviral protein cyanovirin revealed from the crystal structure at 1.35 A resolution.
Fromme R; Katiliene Z; Fromme P; Ghirlanda G
Protein Sci; 2008 May; 17(5):939-44. PubMed ID: 18436959
[TBL] [Abstract][Full Text] [Related]
2. A monovalent mutant of cyanovirin-N provides insight into the role of multiple interactions with gp120 for antiviral activity.
Fromme R; Katiliene Z; Giomarelli B; Bogani F; Mc Mahon J; Mori T; Fromme P; Ghirlanda G
Biochemistry; 2007 Aug; 46(32):9199-207. PubMed ID: 17636873
[TBL] [Abstract][Full Text] [Related]
3. Solution and crystal structures of a sugar binding site mutant of cyanovirin-N: no evidence of domain swapping.
Matei E; Furey W; Gronenborn AM
Structure; 2008 Aug; 16(8):1183-94. PubMed ID: 18682220
[TBL] [Abstract][Full Text] [Related]
4. Solution and crystal molecular dynamics simulation study of m4-cyanovirin-N mutants complexed with di-mannose.
Vorontsov II; Miyashita O
Biophys J; 2009 Nov; 97(9):2532-40. PubMed ID: 19883596
[TBL] [Abstract][Full Text] [Related]
5. Structures of the complexes of a potent anti-HIV protein cyanovirin-N and high mannose oligosaccharides.
Botos I; O'Keefe BR; Shenoy SR; Cartner LK; Ratner DM; Seeberger PH; Boyd MR; Wlodawer A
J Biol Chem; 2002 Sep; 277(37):34336-42. PubMed ID: 12110688
[TBL] [Abstract][Full Text] [Related]
6. Solution structure of a cyanovirin-N:Man alpha 1-2Man alpha complex: structural basis for high-affinity carbohydrate-mediated binding to gp120.
Bewley CA
Structure; 2001 Oct; 9(10):931-40. PubMed ID: 11591348
[TBL] [Abstract][Full Text] [Related]
7. A Designed "Nested" Dimer of Cyanovirin-N Increases Antiviral Activity.
Woodrum BW; Maxwell J; Allen DM; Wilson J; Krumpe LR; Bobkov AA; Hill RB; Kibler KV; O'Keefe BR; Ghirlanda G
Viruses; 2016 Jun; 8(6):. PubMed ID: 27275831
[TBL] [Abstract][Full Text] [Related]
8. Computational study of the dynamics of mannose disaccharides free in solution and bound to the potent anti-HIV virucidal protein cyanovirin.
Margulis CJ
J Phys Chem B; 2005 Mar; 109(8):3639-47. PubMed ID: 16851402
[TBL] [Abstract][Full Text] [Related]
9. Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition.
Barrientos LG; Matei E; Lasala F; Delgado R; Gronenborn AM
Protein Eng Des Sel; 2006 Dec; 19(12):525-35. PubMed ID: 17012344
[TBL] [Abstract][Full Text] [Related]
10. Cyanovirin-N: a sugar-binding antiviral protein with a new twist.
Botos I; Wlodawer A
Cell Mol Life Sci; 2003 Feb; 60(2):277-87. PubMed ID: 12678493
[TBL] [Abstract][Full Text] [Related]
11. A designed chimeric cyanovirin-N homolog lectin: structure and molecular basis of sucrose binding.
Koharudin LM; Furey W; Gronenborn AM
Proteins; 2009 Dec; 77(4):904-15. PubMed ID: 19639634
[TBL] [Abstract][Full Text] [Related]
12. Potent inhibition of HIV-1 fusion by cyanovirin-N requires only a single high affinity carbohydrate binding site: characterization of low affinity carbohydrate binding site knockout mutants.
Chang LC; Bewley CA
J Mol Biol; 2002 Apr; 318(1):1-8. PubMed ID: 12054763
[TBL] [Abstract][Full Text] [Related]
13. Solution structure of a circular-permuted variant of the potent HIV-inactivating protein cyanovirin-N: structural basis for protein stability and oligosaccharide interaction.
Barrientos LG; Louis JM; Ratner DM; Seeberger PH; Gronenborn AM
J Mol Biol; 2003 Jan; 325(1):211-23. PubMed ID: 12473463
[TBL] [Abstract][Full Text] [Related]
14. The potent anti-HIV protein cyanovirin-N contains two novel carbohydrate binding sites that selectively bind to Man(8) D1D3 and Man(9) with nanomolar affinity: implications for binding to the HIV envelope protein gp120.
Bewley CA; Otero-Quintero S
J Am Chem Soc; 2001 May; 123(17):3892-902. PubMed ID: 11457139
[TBL] [Abstract][Full Text] [Related]
15. A Rigid Hinge Region Is Necessary for High-Affinity Binding of Dimannose to Cyanovirin and Associated Constructs.
Li Z; Bolia A; Maxwell JD; Bobkov AA; Ghirlanda G; Ozkan SB; Margulis CJ
Biochemistry; 2015 Nov; 54(46):6951-60. PubMed ID: 26507789
[TBL] [Abstract][Full Text] [Related]
16. Computational models explain the oligosaccharide specificity of cyanovirin-N.
Fujimoto YK; Terbush RN; Patsalo V; Green DF
Protein Sci; 2008 Nov; 17(11):2008-14. PubMed ID: 18809850
[TBL] [Abstract][Full Text] [Related]
17. Multivalent interactions with gp120 are required for the anti-HIV activity of Cyanovirin.
Liu Y; Carroll JR; Holt LA; McMahon J; Giomarelli B; Ghirlanda G
Biopolymers; 2009; 92(3):194-200. PubMed ID: 19235857
[TBL] [Abstract][Full Text] [Related]
18. Analysis of sequence requirements for biological activity of cyanovirin-N, a potent HIV (human immunodeficiency virus)-inactivating protein.
Mori T; Shoemaker RH; Gulakowski RJ; Krepps BL; McMahon JB; Gustafson KR; Pannell LK; Boyd MR
Biochem Biophys Res Commun; 1997 Sep; 238(1):218-22. PubMed ID: 9299482
[TBL] [Abstract][Full Text] [Related]
19. Atomic mapping of the interactions between the antiviral agent cyanovirin-N and oligomannosides by saturation-transfer difference NMR.
Sandström C; Berteau O; Gemma E; Oscarson S; Kenne L; Gronenborn AM
Biochemistry; 2004 Nov; 43(44):13926-31. PubMed ID: 15518540
[TBL] [Abstract][Full Text] [Related]
20. Designed oligomers of cyanovirin-N show enhanced HIV neutralization.
Keeffe JR; Gnanapragasam PN; Gillespie SK; Yong J; Bjorkman PJ; Mayo SL
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14079-84. PubMed ID: 21799112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
